$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2021 Form 10-K Financial Statement

#000162828022008830 Filed on April 08, 2022

Income Statement

Concept	2021	2020 Q4	2020
Revenue	$61.93M	$15.16M	$62.20M
YoY Change	-0.43%	-2.13%	1.46%
Cost Of Revenue	$64.35M	$14.78M	$59.47M
YoY Change	8.2%	2.78%	1.72%
Gross Profit	-$2.420M	$390.0K	$2.725M
YoY Change	-188.81%	-64.86%	-4.02%
Gross Profit Margin	-3.91%	2.57%	4.38%
Selling, General & Admin	$21.08M	$6.550M	$24.05M
YoY Change	-12.36%	-0.15%	-19.95%
% of Gross Profit		1679.49%	882.68%
Research & Development	$6.800M	$1.910M	$7.100M
YoY Change	-4.23%	-2.55%	2.9%
% of Gross Profit		489.74%	260.55%
Depreciation & Amortization	$668.0K	$220.0K	$834.0K
YoY Change	-19.9%	4.76%	5.84%
% of Gross Profit		56.41%	30.61%
Operating Expenses	$27.88M	$8.460M	$31.15M
YoY Change	-10.5%	-0.59%	-15.68%
Operating Profit	-$30.34M	-$8.070M	-$28.42M
YoY Change	6.74%	9.05%	-17.68%
Interest Expense	$2.360M	-$590.0K	$1.879M
YoY Change	25.6%	-690.0%	7416.0%
% of Operating Profit
Other Income/Expense, Net	-$2.338M	$0.00	-$2.470M
YoY Change	-5.34%		-722.17%
Pretax Income	-$32.67M	-$8.660M	-$30.89M
YoY Change	5.78%	18.63%	-9.49%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$32.67M	-$8.660M	-$30.89M
YoY Change	5.78%	18.63%	-9.49%
Net Earnings / Revenue	-52.76%	-57.12%	-49.66%
Basic Earnings Per Share	-$0.35		-$0.41
Diluted Earnings Per Share	-$0.35	-$92.42K	-$0.41
COMMON SHARES
Basic Shares Outstanding	93.79M shares	93.57M shares	75.62M shares
Diluted Shares Outstanding	93.79M shares		75.62M shares

Balance Sheet

Concept	2021	2020 Q4	2020
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.44M	$58.68M	$58.68M
YoY Change	-61.76%	125.3%	125.35%
Cash & Equivalents	$13.28M	$48.68M	$48.68M
Short-Term Investments	$9.158M	$9.997M	$10.00M
Other Short-Term Assets	$2.861M	$2.710M	$2.710M
YoY Change	5.57%	-9.06%	-9.06%
Inventory	$4.076M	$3.913M	$3.910M
Prepaid Expenses
Receivables	$5.913M	$4.171M	$4.170M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$35.29M	$69.47M	$69.47M
YoY Change	-49.2%	88.4%	88.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.22M	$2.642M	$5.550M
YoY Change	84.2%	8.59%	-1.77%
Goodwill		$900.0K
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.142M	$629.0K	$1.810M
YoY Change	18.34%	44.6%	108.05%
Total Long-Term Assets	$13.29M	$8.279M	$8.280M
YoY Change	60.46%	11.23%	11.14%
TOTAL ASSETS
Total Short-Term Assets	$35.29M	$69.47M	$69.47M
Total Long-Term Assets	$13.29M	$8.279M	$8.280M
Total Assets	$48.57M	$77.75M	$77.75M
YoY Change	-37.53%	75.44%	75.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.739M	$4.155M	$4.160M
YoY Change	-10.12%	37.67%	37.75%
Accrued Expenses	$7.094M	$5.013M	$6.180M
YoY Change	14.79%	10.96%	2.83%
Deferred Revenue		$2.175M
YoY Change		-2.64%
Short-Term Debt	$437.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due	$7.381M	$0.00
YoY Change
Total Short-Term Liabilities	$20.97M	$12.79M	$12.79M
YoY Change	63.92%	3.39%	3.4%
LONG-TERM LIABILITIES
Long-Term Debt	$13.19M	$20.95M	$20.95M
YoY Change	-37.06%
Other Long-Term Liabilities	$11.89M	$0.00	$9.840M
YoY Change	20.8%	-100.0%	-15.32%
Total Long-Term Liabilities	$25.07M	$20.95M	$30.79M
YoY Change	-18.57%		164.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.97M	$12.79M	$12.79M
Total Long-Term Liabilities	$25.07M	$20.95M	$30.79M
Total Liabilities	$46.04M	$43.58M	$43.58M
YoY Change	5.64%	81.6%	81.58%
SHAREHOLDERS EQUITY
Retained Earnings		-$337.4M
YoY Change		10.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.535M	$34.17M	$34.17M
YoY Change
Total Liabilities & Shareholders Equity	$48.57M	$77.75M	$77.75M
YoY Change	-37.53%	75.44%	75.43%

Cashflow Statement

Concept	2021	2020 Q4	2020
OPERATING ACTIVITIES
Net Income	-$32.67M	-$8.660M	-$30.89M
YoY Change	5.78%	18.63%	-9.49%
Depreciation, Depletion And Amortization	$668.0K	$220.0K	$834.0K
YoY Change	-19.9%	4.76%	5.84%
Cash From Operating Activities	-$33.50M	-$8.570M	-$29.64M
YoY Change	13.02%	61.7%	8.76%
INVESTING ACTIVITIES
Capital Expenditures	-$522.0K	-$80.00K	-$1.050M
YoY Change	-50.29%	-42.86%	77.97%
Acquisitions
YoY Change
Other Investing Activities	$833.0K	$710.0K	$4.260M
YoY Change	-80.45%	129.03%	-202.4%
Cash From Investing Activities	$311.0K	$630.0K	$3.212M
YoY Change	-90.32%	270.59%	-167.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.179M	0.000	$63.32M
YoY Change	-103.44%	-100.0%	200.29%
NET CHANGE
Cash From Operating Activities	-$33.50M	-8.570M	-$29.64M
Cash From Investing Activities	$311.0K	630.0K	$3.212M
Cash From Financing Activities	-$2.179M	0.000	$63.32M
Net Change In Cash	-$35.40M	-7.940M	$36.89M
YoY Change	-195.97%	201.9%	-437.82%
FREE CASH FLOW
Cash From Operating Activities	-$33.50M	-$8.570M	-$29.64M
Capital Expenditures	-$522.0K	-$80.00K	-$1.050M
Free Cash Flow	-$32.98M	-$8.490M	-$28.59M
YoY Change	15.34%	64.53%	7.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001041024
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://rockwellmed.com/20211231#FinanceAndOperatingLeaseLiabilityCurrent http://rockwellmed.com/20211231#FinanceAndOperatingLeaseLiabilityNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://rockwellmed.com/20211231#FinanceAndOperatingLeaseLiabilityCurrent http://rockwellmed.com/20211231#FinanceAndOperatingLeaseLiabilityNoncurrent
CY2021	dei	Entity File Number EntityFileNumber	000-23661
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Registrant Name EntityRegistrantName	ROCKWELL MEDICAL, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3317208
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	30142 S. Wixom Road
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Wixom
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48393
CY2021	dei	City Area Code CityAreaCode	248
CY2021	dei	Local Phone Number LocalPhoneNumber	960‑9009
CY2021	dei	Security12b Title Security12bTitle	Common Stock, par value $.0001
CY2021	dei	Trading Symbol TradingSymbol	RMTI
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	29007276	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	93986470	shares
CY2021	dei	Auditor Name AuditorName	Marcum LLP
CY2021	dei	Auditor Firm AuditorFirmId	688
CY2021	dei	Auditor Location AuditorLocation	Chicago, Illinois
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13280000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48682000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9158000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9997000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5913000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4171000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	4076000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	3913000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2861000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2706000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	35288000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	69469000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2486000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2642000	USD
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1523000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1176000	USD
CY2021Q4	rmti	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	7737000	USD
CY2020Q4	rmti	Operating And Finance Lease Right Of Use Asset OperatingAndFinanceLeaseRightOfUseAsset	2911000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	921000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	921000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	619000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	629000	USD
CY2021Q4	us-gaap	Assets Assets	48574000	USD
CY2020Q4	us-gaap	Assets Assets	77748000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3739000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4155000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5090000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5013000	USD
CY2021Q4	rmti	Finance And Operating Lease Liability Current FinanceAndOperatingLeaseLiabilityCurrent	2004000	USD
CY2020Q4	rmti	Finance And Operating Lease Liability Current FinanceAndOperatingLeaseLiabilityCurrent	1167000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2171000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2175000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7381000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	437000	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	0	USD
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	144000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	152000	USD
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	131000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20966000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12793000	USD
CY2021Q4	rmti	Finance And Operating Lease Liability Noncurrent FinanceAndOperatingLeaseLiabilityNoncurrent	5887000	USD
CY2020Q4	rmti	Finance And Operating Lease Liability Noncurrent FinanceAndOperatingLeaseLiabilityNoncurrent	1821000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13186000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20949000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5986000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8015000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	46039000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	43578000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2020Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93986470	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93986470	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93573165	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93573165	shares
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	9000	USD
CY2020Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	9000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	372554000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371510000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-370080000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-337406000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	52000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	57000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2535000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34170000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	48574000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77748000	USD
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	61931000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	62197000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	64351000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	59472000	USD
CY2021	us-gaap	Gross Profit GrossProfit	-2420000	USD
CY2020	us-gaap	Gross Profit GrossProfit	2725000	USD
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6835000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7092000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5733000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7871000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15348000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16182000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-30336000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-28420000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	8000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	837000	USD
CY2021	us-gaap	Interest Expense InterestExpense	2360000	USD
CY2020	us-gaap	Interest Expense InterestExpense	1879000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	22000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	238000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2338000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2470000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32674000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30890000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93788050	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	93788050	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75621674	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75621674	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32674000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30890000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32679000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30885000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	20320000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30890000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-19000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	501000	USD
CY2020	rmti	Adjustmentsto Additional Paidin Capital Warrant Modification Expense AdjustmentstoAdditionalPaidinCapitalWarrantModificationExpense	837000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	475000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34170000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32674000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-6000	USD
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	107000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	943000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2535000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-32674000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-30890000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	668000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	834000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	943000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	475000	USD
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	837000	USD
CY2021	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	146000	USD
CY2020	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	305000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1847000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1455000	USD
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	369000	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	294000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-8000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-7000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	8000	USD
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2000	USD
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1742000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-32000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	656000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1306000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1823000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-76000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-416000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1136000	USD
CY2021	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-104000	USD
CY2021Q4	rmti	Working Capital Net WorkingCapitalNet	14300000	USD
CY2021	rmti	Increase Decreasein Operating Lease Liabilities IncreaseDecreaseinOperatingLeaseLiabilities	1771000	USD
CY2020	rmti	Increase Decreasein Operating Lease Liabilities IncreaseDecreaseinOperatingLeaseLiabilities	1439000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-48000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	534000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2033000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1887000	USD
CY2021	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	4843000	USD
CY2020	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2958000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33534000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-29641000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	26058000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	29307000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	26891000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	33565000	USD
CY2021	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	522000	USD
CY2020	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1046000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33500000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-370100000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	311000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3212000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	22500000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1343000	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1530000	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	763000	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	750000	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	107000	USD
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2021	rmti	Repurchase Of Common Shares To Pay Employee Withholding Taxes RepurchaseOfCommonSharesToPayEmployeeWithholdingTaxes	6000	USD
CY2020	rmti	Repurchase Of Common Shares To Pay Employee Withholding Taxes RepurchaseOfCommonSharesToPayEmployeeWithholdingTaxes	19000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2179000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63316000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-35402000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2500000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	22400000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	36887000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48682000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11795000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13280000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48682000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1827000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1558000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-6000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3000	USD
CY2021	rmti	Research And Development Licenses Included In Settlement Payable ResearchAndDevelopmentLicensesIncludedInSettlementPayable	437000	USD
CY2020	rmti	Research And Development Licenses Included In Settlement Payable ResearchAndDevelopmentLicensesIncludedInSettlementPayable	0	USD
CY2021	us-gaap	Stock Issued1 StockIssued1	501000	USD
CY2020	us-gaap	Stock Issued1 StockIssued1	501000	USD
CY2021	rmti	Years Of Service YearsOfService	P25Y
CY2021	rmti	Entity Yearly Revenue EntityYearlyRevenue	60000000	USD
CY2021Q4	dei	Entity Number Of Employees EntityNumberOfEmployees	300	employee
CY2021	rmti	Number Of Major Customers NumberOfMajorCustomers	2	agreement
CY2021	rmti	Number Of Distribution And License Agreements NumberOfDistributionAndLicenseAgreements	5	agreement
CY2021	rmti	Average Payment Term Of Customers AveragePaymentTermOfCustomers	P30D
CY2021	rmti	Average Payment Term Of Distributors AveragePaymentTermOfDistributors	P45D
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	61931000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	62197000	USD
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6800000	USD
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7100000	USD
CY2021Q4	us-gaap	Other Receivables OtherReceivables	5913000	USD
CY2020Q4	us-gaap	Other Receivables OtherReceivables	4171000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8157000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10190000	USD
CY2021	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2020	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2021	rmti	Bad Debt Expense BadDebtExpense	0	USD
CY2020	rmti	Bad Debt Expense BadDebtExpense	0	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	8200000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10200000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates. The most significant accounting estimates inherent in the preparation of our financial statements include estimates associated with fair value and classification of warrants, revenue recognition, allowance for doubtful accounts, inventory reserves, accrued expenses, deferred license revenue, stock-based compensation, impairments of long-lived assets, and accounting for income taxes.</span></div>
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P17Y
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1900000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2000000	USD
CY2021Q4	us-gaap	Notes Payable NotesPayable	400000	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32641851	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33307113	shares
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9143000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	14000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9158000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9987000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9997000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1805000	USD
CY2021Q4	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	5599000	USD
CY2020Q4	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	5089000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3434000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3112000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	201000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	172000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1964000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9589000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9178000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2642000	USD
CY2021	us-gaap	Depreciation Depreciation	668000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7103000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6536000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2486000	USD
CY2020	us-gaap	Depreciation Depreciation	834000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	900000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	366000	USD
CY2020Q4	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	232000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1791000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2500000	USD
CY2021Q4	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	796000	USD
CY2020Q4	rmti	Accrued Unvouchered Receipts Current AccruedUnvoucheredReceiptsCurrent	755000	USD
CY2021Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	382000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	395000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1755000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1131000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5090000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5013000	USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93573165	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93986470	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93986470	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93573165	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	943000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	475000	USD
CY2018Q4	rmti	Number Of Additional Agreements NumberOfAdditionalAgreements	3	agreement
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1793000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	1609000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	373000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	488000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	2166000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	2097000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	313000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	18000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	99000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5000	USD
CY2021	rmti	Finance Lease Expense FinanceLeaseExpense	412000	USD
CY2020	rmti	Finance Lease Expense FinanceLeaseExpense	23000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	17000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	17000	USD
CY2021	us-gaap	Lease Cost LeaseCost	2595000	USD
CY2020	us-gaap	Lease Cost LeaseCost	2137000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1772000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1648000	USD
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	99000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	5000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	255000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	17000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4217000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	268000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2431000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	930000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y9M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.064
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.051
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	668000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1114000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1772000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	660000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1455000	USD
CY2021	rmti	Self Insurance Overall Limit SelfInsuranceOverallLimit	599000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	671000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	637000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	676000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	259000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	665000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	120000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	311000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5357000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3651000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	555000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	562000	USD
CY2021Q4	rmti	Self Insurance Retention Limits In Excess Of Claims Paid And Accrued SelfInsuranceRetentionLimitsInExcessOfClaimsPaidAndAccrued	431000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4802000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	3089000	USD
CY2021Q4	rmti	Self Insurance Reserve Per Occurrence SelfInsuranceReservePerOccurrence	350000	USD
CY2021Q4	rmti	Self Insurance Estimated Loss Reserves And Additional Future Claims SelfInsuranceEstimatedLossReservesAndAdditionalFutureClaims	382000	USD
CY2021Q4	rmti	Cash Collateral And Escrow Deposit Held By Insurance Carriers For Workers Compensation Insurance CashCollateralAndEscrowDepositHeldByInsuranceCarriersForWorkersCompensationInsurance	400000	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	32600000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2262
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2267
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6744000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6373000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	0	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6744000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6373000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66895000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	59586000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7726000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2310000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7582000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1846000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	6872000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	6872000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	174000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	185000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	88000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	666000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	6000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	25000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	865000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	387000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	84472000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	77613000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	183000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	155000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	381000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	294000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	564000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	449000	USD
CY2021Q4	rmti	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	83908000	USD
CY2020Q4	rmti	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	77164000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83908000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	77164000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	294800000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q4	us-gaap	Deferred Taxes Business Combination Valuation Allowance Allocated To Contributed Capital DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital	4200000	USD

Files In Submission

Name	View Source	Status
0001628280-22-008830-index-headers.html	Edgar Link	pending
0001628280-22-008830-index.html	Edgar Link	pending
0001628280-22-008830.txt	Edgar Link	pending
0001628280-22-008830-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmti-20211231.htm	Edgar Link	pending
rmti-20211231.xsd	Edgar Link	pending
rmti-20211231x10kxex311.htm	Edgar Link	pending
rmti-20211231x10kxex312.htm	Edgar Link	pending
rmti-20211231x10kxex321.htm	Edgar Link	pending
rmti-20211231x10kxex42.htm	Edgar Link	pending
rmti-20211231x10kxexx231.htm	Edgar Link	pending
rmti-20211231_cal.xml	Edgar Link	unprocessable
rmti-20211231_def.xml	Edgar Link	unprocessable
rmti-20211231_g1.jpg	Edgar Link	pending
rmti-20211231_g2.jpg	Edgar Link	pending
rmti-20211231_g3.jpg	Edgar Link	pending
rmti-20211231_g4.jpg	Edgar Link	pending
rmti-20211231_g5.jpg	Edgar Link	pending
rmti-20211231_g6.jpg	Edgar Link	pending
rmti-20211231_g7.jpg	Edgar Link	pending
rmti-20211231_g8.jpg	Edgar Link	pending
rmti-20211231_htm.xml	Edgar Link	completed
rmti-20211231_lab.xml	Edgar Link	unprocessable
rmti-20211231_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2021 Form 10-K Financial Statement

#000162828022008830 Filed on April 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2021 Form 10-K Financial Statement

#000162828022008830 Filed on April 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti